References
- González-Chávez SA, Arévalo-Gallegos S, Rascón-Cruz Q. Lactoferrin: structure, function and applications. Int J Antimicrob Agents 2009;33:301e1–8
- Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995;80:252–67
- Roseanu A, Brock JH. Is there an answer? What are the structure and the biological function of lactoferrin in human breast milk? IUBMB Life 2006;58:235–7
- Berlutti F, Pantanella F, Natalizi T, et al. Antiviral properties of lactoferrin-a natural immunity molecule. Molecules 2011;16:6992–7018
- Florian PE, Trif M, Evans RW, Roseanu A. An overview on the antiviral activity of lactoferrin. Rom J Biochem 2009;46:187–97
- Conneely OM. Anti-inflammatory activities of lactoferrin. J Am Coll Nutr 2001;20:389S–95S
- Manzoni P, Stolfi I, Messner H, et al Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 2012;129:116–23
- Sánchez L, Calvo M, Brock JH. Biological role of lactoferrin. Arc Dis Child 1992;67:657–61
- Adlerova L, Bartoskova A, Faldyna M. Lactoferrin: a review. Vet Med 2008;53:457–68
- Cornish J, Callon KE, Naot D, et al Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 2004;145:4366–74
- Kurien M, Sidhu R, Sanders DS. Fecal lactoferrin: a clinically useful test in the management of inflammatory bowel disease and irritable bowel syndrome. AGH 2012;3:89–93
- Lamb CA, Mansfield JC. Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease. Frontline Gastroenterol 2011;2:13–18
- Joishy M, Davies I, Ahmed M, et al Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009;48:48–54
- Walker TR, Land ML, Kartashov A, et al Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007;44:414–22
- Kane SV, Sandborn WJ, Rufo PA, et al Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309–14
- Däbritz J, Musci J, Foell D. Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome. World J Gastroenterol 2014;20:363–75
- Turkay C, Kasapoglu B. Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics (Sao Paulo) 2010;65:221–31
- Schröder O, Naumann M, Shastri Y, et al Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Aliment Pharmacol Ther 2007;26:1035–42
- Buderus S, Boone JH, Lentze MJ. Fecal lactoferrin: reliable biomarker for intestinal inflammation in pediatric IBD. Gastroenterol Res Pract 2015;2015:578527. DOI: 10.1155/2015/578527
- Bekkali N, Hamers SL, Schipperus MR, et al Duration of meconium passage in preterm and term infants. Arch Dis Child Fetal Neonatal Ed 2008;93:F376–9
- Setu M, Mollah MAH, Amin SK, et al Duration of meconium passage in term and preterm infants. Akmmc J 2013;4:6–9
- Sipponen T. Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactoferrin. Dig Dis 2013;31:336–44
- Kopylov U, Rosenfeld G, Bressler B, Seidman E. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease. Inflamm Bowel Dis 2014;20:742–56
- Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379–90
- Yuan Q, Walker WA. Innate immunity of the gut: mucosal defense in health and disease. J Pediatr Gastroenterol Nutr 2004;38:463–73
- Pang T, Leach ST, Katz T, et al Fecal biomarkers of intestinal health and disease in children. Front Pediatr 2014;2:1–12
- Embleton ND, Berrington JE, McGuire W, et al Lactoferrin: antimicrobial activity and therapeutic potential. Semin Fetal Neonatal Med 2013;18:143–9
- Turin CG, Zea-Vera A, Pezo A, et al NEOLACTO Research Group. Lactoferrin for prevention of neonatal sepsis. Biometals 2014;27:1007–16
- The ELFIN Trial Investigators Group. Lactoferrin immunoprophylaxis for very preterm infants. Arch Dis Child Fetal Neonatal Ed 2013;98:F2–4
- Sharma D, Shastri S. Lactoferrin and neonatology – role in neonatal sepsis and necrotizing enterocolitis: present, past and future. J Matern Fetal Neonatal Med 2016;29:763–70